Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5841373 | Life Sciences | 2016 | 41 Pages |
Abstract
Our study showed that rHuEPO-induced hypertension is present before significant hematological changes occur and, therefore, might involve direct (renal) and indirect (hematological) effects, which varies according to the dose used. The presence of renal hypoxia reduces eNOS activity. Excessive erythrocytosis increases blood hyperviscosity, which can be modulated by an increase in reticulocytes. Hypertension leads to early renal damage without alterations in traditional markers of renal function, thus underestimating the serious adverse effects and risks.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sandra Ribeiro, PatrÃcia Garrido, João Fernandes, Helena Vala, Petronila Rocha-Pereira, ElÃsio Costa, LuÃs Belo, Flávio Reis, Alice Santos-Silva,